News You Can Use

Recent advances in brain and spine imaging

by jmiller on May 12, 2015

Advanced MR imaging techniques have found extensive utility in the clinical practice of neuroradiology. A variety of these techniques are incorporated into imaging protocols for routine use, specific applications to particular disease entities, or as problem-solving tools on an ad hoc basis. This article summarizes and illustrates the spectrum of advanced MR imaging tools used clinically in the practice of neuroradiology.  (Radiol Clin N A, May)  Click here to read full-text.

Thank you, AAMC Nursing Staff!

by jmiller on May 11, 2015

At the Nurse’s Dinner last week, I had the unexpected pleasure of receiving  the “AAMC Nursing Colleague Excellence Award”.  It is an honor and a privilege to receive this award and to work with such a fabulous nursing staff.  Thank you!

-Joyce Miller, Medical Librarian

What’s the evidence for evidence based medicine?

by jmiller on May 11, 2015

“What’s in a name?  The answer begins with the name, which physicians find both amusing and insulting, as if in the dark ages before EBM, physicians practiced without evidence.  EBM’s power comes in part, from branding. The art and alchemy of medicine reside not in evidence based guidelines, but in the mind and expertise of committed physicians.  The challenge for EBM is keeping the patient front and center while negotiating the vagaries of the evidence.”  (Maryland Medicine, May)  Click here to read full text.

Should patients stop taking aspirin for primary prevention?

by jmiller on May 11, 2015

“In view of current evidence, we do not recommend routinely using aspirin for pimary prevention of cardiovascular disease, even in patients with diabetes mellitus.  The decision must be indificualized on the basis of the patient’s risks of cardiovascular disease and bleeding, especiallly the risk of serious bleeding events such as gastrointestinal and intracranial hemorrhage.”  (Cleve Clin J Med, Feb)   Click here to read full text.

Preoperative medical testing in medicare patients undergoing cataract surgery

by jmiller on April 16, 2015

“Routine preoperative testing is not recommended for patients undergoing cataract surgery, because testing neither decreases adverse events nor improves outcomes. Preoperative testing before cataract surgery occurred frequently and was more strongly associated with provider practice patterns than with patient characteristics.  Furthermore, the results showed no difference in the prevalence of testing as compared with 20 years ago, before the introduction of guidelines stating that routine properative testing for cataract surgery was not necessary.  (NEJM, April 16). Click here to read full text.

New hypertension guidelines: One size fits most?

by jmiller on April 10, 2015

“The report of the panel appointed to the eight Joing National Committee on prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC8) is more evidence-based and focused than its predecessors, outlining a management strategy that is simpler and, in some instances, less aggressive.  It has both strengths and weaknesses.  This article reviews the major components.  Click here to read full text.

Should patients stop taking aspirin for primary prevention?

by jmiller on April 10, 2015

“Based on the current available evidence, the US Food and Drug Administration recently issued a Consumer Update that does not support aspirin for primary prevention and warns patients about the risk of serious bleeding complications.  Moreover, current guidelines and consensus panels for aspirin in primary prevention differ from one another, making it challenging for clinicians to determine which patients would benefit. One message is clear in the most current clinical guidelines, namely, that routine use of aspirin for primary prevention is not recommended.”  (Cleve Clin J, April)  Click here to read full-text.

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions

by Medical Staff Office on March 27, 2015

Women with germline mutations in the cancer susceptibility genes, BRCA1 or BRCA2, associated with Hereditary Breast and Ovarian Cancer syndrome, have up to an 85% lifetime risk of breast cancer and up to a 46% lifetime risk of ovarian, tubal and peritoneal cancers.    The article addresses lynch/Hereditary Non-Polyposis Colorectal Cancer (HNPCC) syndrome as well.  This commentary provides guidance on identification of patients who may benefit from assessment for the presence of a hereditary breast and/or gynecologic cancer syndrome.  (Gynecol Oncol, April 2014)  Click here to read full text.

Older posts «

» Newer posts